All Stories

  1. Semisynthetic, self-adjuvanting vaccine development: Efficient, site-specific sortase A-mediated conjugation of Toll-like receptor 2 ligand FSL-1 to recombinant protein antigens under native conditions and application to a model group A streptococcal v...
  2. Gastrin-releasing peptide receptor-targeted hybrid peptide/phospholipid pDNA/siRNA delivery systems
  3. Preparation of albendazole-loaded liposomes by supercritical carbon dioxide processing
  4. Modifications to Glucagon-like peptide-1 (GLP-1) for type 2 diabetes and weight loss treatments
  5. Improving vaccines by attaching immunostimulatory Toll-like receptor ligands onto protein antigens
  6. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells
  7. Approaches to increase or tailor immune responses towards protein vaccine antigens
  8. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery
  9. Investigation of bombesin peptide as a targeting ligand for the gastrin releasing peptide (GRP) receptor
  10. Peptide-Based Multicomponent Oligonucleotide Delivery Systems: Optimisation of Poly-l-lysine Dendrons for Plasmid DNA Delivery
  11. Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models
  12. Optimization of endosome escape activity of multicomponent DNA delivery systems
  13. Double conjugation strategy to incorporate lipid adjuvants into multiantigenic vaccines
  14. Semisynthetic, recombinant, non-oncogenic HPV-16 E7 lipoprotein vaccine against cervical cancer
  15. Strategies to improve the escape of gene delivery platforms from endosomes
  16. Peptide based DNA nanocarriers incorporating a cell-penetrating peptide derived from neurturin protein and poly-l-lysine dendrons
  17. Progress in Vaccine Development
  18. Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity
  19. Efficient method to incorporate TLR2 ligands into recombinant protein antigens
  20. Polymer–peptide hybrids as a highly immunogenic single-dose nanovaccine
  21. Simple means to incorporate a synthetic LCP adjuvant into a recombinant vaccine antigen
  22. ChemInform Abstract: Modern Subunit Vaccines: Development, Components, and Research Opportunities
  23. Modern Subunit Vaccines: Development, Components, and Research Opportunities
  24. Synthesis and Characterization of Luteinizing Hormone-Releasing Hormone (LHRH)-Functionalized Mini-Dendrimers
  25. Method for the Synthesis of Mono-ADP-ribose Conjugated Peptides
  26. Modern lipid-, carbohydrate-, and peptide-based delivery systems for peptide, vaccine, and gene products
  27. Vaccine Delivery: Synthesis and Investigation of a Highly Pure, Multi-Epitopic Lipopeptide Vaccine Candidate
  28. Vaccine delivery utilizing liposaccharides
  29. Strategies in Oral Immunization
  30. Development of a Liposaccharide-Based Delivery System and Its Application to the Design of Group A Streptococcal Vaccines
  31. The incorporation of lipids into peptide vaccines to stimulate the immune system
  32. Structure–Activity Relationship of a Series of Synthetic Lipopeptide Self-Adjuvanting Group A Streptococcal Vaccine Candidates
  33. Investigation toward multi-epitope vaccine candidates using native chemical ligation
  34. Towards the Development of a Broadly Protective Group A Streptococcal Vaccine Based on the Lipid-Core Peptide System
  35. Toward the Development of Prophylactic and Therapeutic Human Papillomavirus Type-16 Lipopeptide Vaccines
  36. A technique for the synthesis of highly-pure, mono-epitopic, multi-valent lipid core peptide vaccines
  37. Synthesis of a Highly Pure Lipid Core Peptide Based Self-Adjuvanting Triepitopic Group A Streptococcal Vaccine, and Subsequent Immunological Evaluation
  38. Method for the Synthesis of Multi-Epitopic Streptococcus pyogenes Lipopeptide Vaccines Using Native Chemical Ligation
  39. Synthesis and Immunological Evaluation of M Protein Targeted Tetra-Valent and Tri-Valent Group A Streptococcal Vaccine Candidates Based on the Lipid-Core Peptide System
  40. The lipid core peptide system in vaccine delivery
  41. Method for the synthesis of highly pure vaccines using the lipid core peptide system
  42. Mucosal Immunisation: Adjuvants and Delivery Systems
  43. Development of lipid-core-peptide (LCP) based vaccines for the prevention of group A streptococcal (GAS) infection
  44. Development of Peptide Vaccines against HPV-16 Associated Cervical Cancer and Group A Streptococci